This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
How High Will the Market Go?
Based on the S&P 500's breakout from a reverse head-and-shoulders in January, the target for 2013 is 1,607. More
Will Summer Movies Heat Up Media Stocks?
Summer is a hot season for movies. Will these upcoming blockbuster hopefuls be enough to move the needle on media stocks? Take a look. More
3 ‘Stealth Pullback’ Stocks to Buy
Rather than buying high fliers in this overbought market, look for stocks that have already experienced a healthy correction on their own but remain technically strong. More
10 Worst “Strong Sell” Stocks This Week — HMY SVM EXK and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader. Since the beginning of the year, the Nasdaq rose 3.5%, the Dow rose 6.6%, and the S&P has risen 5.4%. More
5 Stocks With Awful Earnings Surprises — WPC CBB ROMA MOD NX
This week, these five stocks have the worst ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader. More
